Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the prevalence of transthyretin cardiac amyloidosis
(TTR-CA) among patients with moderate and severe aortic stenosis in Southeast Minnesota using
99mTc-PYP single-photon positive emission computed tomography with computed tomography
(SPECT/CT).